Safety and Tolerability of Seroguard Use

NCT03640559 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Adhesion

Interventions

DRUG: Seroguard
DRUG: Placebos

Sponsor

Pharmasyntez

Collaborators

[object Object]